Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent | 
|---|---|---|---|---|---|
| 10/31/2025 | PUT | $210.00 | 4,398 | +3,830 | +674.30% | 
| 11/07/2025 | CALL | $230.00 | 2,713 | +2,478 | +1,054.47% | 
| 11/07/2025 | CALL | $240.00 | 2,696 | +2,163 | +405.82% | 
| 10/31/2025 | PUT | $217.50 | 5,060 | +1,002 | +24.69% | 
| 11/07/2025 | PUT | $222.50 | 710 | +696 | +4,971.43% | 
| 10/31/2025 | PUT | $215.00 | 1,212 | +549 | +82.81% | 
| 03/20/2026 | PUT | $175.00 | 465 | -64 | -12.10% | 
| 10/31/2025 | CALL | $232.50 | 636 | -72 | -10.17% | 
| 02/20/2026 | CALL | $200.00 | 134 | -93 | -40.97% | 
| 01/15/2027 | CALL | $150.00 | 157 | -127 | -44.72% | 
| 01/16/2026 | PUT | $230.00 | 857 | -136 | -13.70% | 
| 12/19/2025 | CALL | $240.00 | 13,289 | -747 | -5.32% | 
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total | 
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.05% | 53.76M | 7.26B | 
| Vanguard 500 Index Fund | 2.32% | 40.88M | 5.52B | 
| Fidelity 500 Index Fund | 1.10% | 19.39M | 2.62B | 
| SPDR S&P 500 ETF Trust | 1.09% | 19.15M | 2.58B | 
| American Mutual Fund Inc | 1.00% | 17.6M | 2.38B | 
| iShares Core S&P 500 ETF | 0.89% | 15.78M | 2.13B | 
| Vanguard Index-Value Index Fund | 0.87% | 15.28M | 2.06B | 
| Capital Income Builder, Inc. | 0.84% | 14.87M | 2.01B | 
| Select Sector SPDR Fund-Health Care | 0.81% | 14.36M | 1.94B | 
| Washington Mutual Investors Fund | 0.75% | 13.22M | 1.78B | 
AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend
10/31 11:47 am
Benzinga
Read moreAnti-Inflammatory Drugs Market to Reach USD 274.79 Billion by 2034, Fueled by Rising Innovation and Accessibility
10/31 11:00 am
GlobeNewswire Inc.
Read moreNxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025
10/31 02:35 am
GlobeNewswire Inc.
Read moreWant Decades of Passive Income? Buy This Index Fund and Hold It Forever.
10/28 08:27 am
The Motley Fool
Read moreBillionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?
10/28 06:26 am
The Motley Fool
Read morePrediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade
10/26 11:21 am
The Motley Fool
Read moreAbbVie Draws Growing Institutional Confidence As Investors Seek Steady Growth
10/23 01:07 pm
The Motley Fool
Read moreBullish Bet: Investment Manager Makes Strategic Buy of Prologis Stock
10/23 10:33 am
The Motley Fool
Read moreUnited States Breast Reconstruction Market Growth Trends and Forecast Report 2025-2033, Profiles of Mentor Worldwide, AbbVie, Integra, Sientra, Stryker, Establishment Labs, RTI Surgical, TELA Bio
10/23 04:52 am
GlobeNewswire Inc.
Read moreAbacus FCF Advisors Bets $16 Million on Hilton Even as Hotel Stock Lags Market
10/21 03:12 pm
The Motley Fool
Read moreGlobal Liquid Filters Market to Reach US$ 26.5 Billion by 2033 | Astute Analytica
10/20 12:30 pm
GlobeNewswire Inc.
Read more3 Dividend-Paying ETFs to Double Down On Even if the S&P 500 Sells Off in October
10/20 08:21 am
The Motley Fool
Read moreOSE Immunotherapeutics Reports First Half 2025 Financial Results
10/15 01:00 pm
GlobeNewswire Inc.
Read moreOSE Immunotherapeutics publie ses résultats financiers du 1er semestre 2025
10/15 01:00 pm
GlobeNewswire Inc.
Read moreThe Best Dividend ETF to Invest $500 in Right Now
10/14 04:15 am
The Motley Fool
Read moreThe Best Dividend ETF to Invest $1,000 in Right Now
10/12 01:05 pm
The Motley Fool
Read moreAesthetics Market to Reach USD 148.27 Billion by 2033, Driven by Surge in Minimally Invasive Procedures and Global Cosmetic Innovation – SNS Insider
10/10 10:00 am
GlobeNewswire Inc.
Read moreHigher Levels of Trust Determine 2025 Fortune 100 Best Companies to Work For Europe
10/09 03:00 am
GlobeNewswire Inc.
Read more3 Exceptional Stocks to Build Long-Term Wealth
10/08 01:23 pm
Investing.com
Read moreWhy AbbVie Stock Cruised to an Almost 6% Gain Today
10/01 06:36 pm
The Motley Fool
Read moreWant Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
10/01 05:25 am
The Motley Fool
Read moreWant Decades of Passive Income? Buy This Index Fund and Hold It Forever
09/29 09:33 pm
The Motley Fool
Read moreNxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
09/29 07:30 pm
GlobeNewswire Inc.
Read moreFc and Glycoengineered Antibodies Market Report 2025: Antibody Therapeutics Surge with 550+ Clinical Pipeline Molecules - Fc Innovations Leading the Charge
09/23 10:59 am
GlobeNewswire Inc.
Read moreTopical Drugs CDMO Market Size to Expand USD 136.71 Billion by 2034
09/18 11:00 am
GlobeNewswire Inc.
Read moreBarrett's Esophagus Strategic Business Report 2025-2030 Featuring 34 Companies - Innovative Diagnostics and Therapies Propel Market Growth
09/15 05:56 am
GlobeNewswire Inc.
Read more1 Green Flag for AbbVie (ABBV) Stock Right Now
09/12 01:30 pm
The Motley Fool
Read moreMeet the Vanguard ETF That Yields More Than Twice the S&P 500 Average and Has Minimal Fees
09/12 05:10 am
The Motley Fool
Read moreBipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight
09/11 01:00 pm
GlobeNewswire Inc.
Read moreWhy This Dividend ETF is Perfectly Balanced for Yield and Growth
09/10 06:23 am
The Motley Fool
Read moreThe Schwab U.S. Dividend Equity ETF (SCHD) Is One of the Leading Blue Chip ETFs in 2025. Here's Why.
09/09 09:30 am
The Motley Fool
Read moreShould Passive Income Investors Be Concerned That 54% of the High-Yield Schwab U.S. Dividend Equity ETF Is in Just 3 Stock Market Sectors?
09/08 06:27 am
The Motley Fool
Read moreAbbVie Declares Quarterly Dividend
09/05 09:07 am
Benzinga
Read moreCould These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
09/04 04:09 am
The Motley Fool
Read moreMultiple Myeloma Market Size Projected USD 49.89 Billion by 2034
09/03 11:00 am
GlobeNewswire Inc.
Read moreHealthcare Valuations Near Multi-Year Lows Suggest Risk–Reward Asymmetry
09/02 09:37 am
Investing.com
Read moreDeal Dispatch: PepsiCo, Sycamore, Dr. Phil, SSENSE, Bain's Chindata Lead M&A, Bankruptcy Moves
08/29 03:20 pm
Benzinga
Read moreDermatology Market to Worth USD 2.75 Billion Size by 2034
08/29 11:00 am
GlobeNewswire Inc.
Read moreAs the Market Rotates, This Healthcare ETF Is Leading the Way
08/26 10:07 am
Investing.com
Read moreAbbVie Strikes $1.2 Billion Agreement For Next-Gen Psychedelic Depression Treatment
08/26 09:26 am
Benzinga
Read moreViking Therapeutics: What's Next?
08/26 06:15 am
The Motley Fool
Read more3 Top Stocks to Build Your Portfolio Around
08/24 09:15 am
The Motley Fool
Read moreGlobal Thyroid Gland Disorder Treatment Market to Increase at a Steady Growth Rate of ~3% by 2032 | DelveInsight
08/21 01:00 pm
GlobeNewswire Inc.
Read moreAbbVie's Patch Baldness Study Finds High Hair Coverage Rates With Investigational Drug Upadacitinib
08/21 10:10 am
Benzinga
Read moreCytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035 | Over 140 Players Now Active in HPAPI & Cytotoxic Drug Contract Manufacturing
08/21 05:59 am
GlobeNewswire Inc.
Read moreQuestex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing
08/20 10:00 am
GlobeNewswire Inc.
Read moreGlobal Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030
08/19 01:54 pm
GlobeNewswire Inc.
Read moreVitiligo Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
08/14 01:00 pm
GlobeNewswire Inc.
Read moreAutoinjectors Market Set to Surpass USD 3.02 Billion by 2030 as Demand for Advanced Drug Delivery Systems Accelerates | MarketsandMarkets™.
08/12 08:00 am
GlobeNewswire Inc.
Read moreAbbVie Inclusion In Medicare Drug Talks Fails To Justify Lawsuit, Court Rules
08/08 02:00 pm
Benzinga
Read more